JPRN-UMIN000050967招募中未知
The frequency of uMRD in Japanese patients with CLL after 24 months of treatment with Venetoclax plus/minus Rituximab in the 2L+ in the real-world setting - Japan CLL-MRD study
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- AbbVie GK
- 入组人数
- 89
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with no data on information on the start and end dates or continuation of treatment with Venetocalx 2. Patients participating in other clinical trials
研究者
相似试验
已完成
不适用
Epidemiological study on Japanese patient with multiple sclerosisClinically isolated syndrome (CIS), Radiologically isolated syndrome (RIS), multiple sclerosis (MS)JPRN-UMIN000038060Kyushu University1,000
已完成
不适用
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in JapanChronic Lymphocytic LeukemiaNCT06362044AbbVie89
尚未招募
不适用
Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19inflammatory bowel disease COVID-19JPRN-UMIN000040656Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine200
未知
1 期
A Two Part Study in Japanese Patients With mCRC, Consisting of an Open-Label Phase I Part to Assess the Safety and Tolerability of AZD2171 in Combination With FOLFOX Followed by a Phase II, Randomised, Double-Blind, Parallel Group Study to Assess the Efficacy of AZD2171 in Combination With FOLFOXMetastatic Colorectal CancerJPRN-jRCT2080220420AstraZeneca
招募中
不适用
Clinical Features in Japanese Patients with Chronic Liver Diseases: A multicenter prospective long observational studyChronic liver diseaseJPRN-UMIN000040277Chiba University1,743